Ligand Pharmaceuticals, Inc. (LGND)
186.64
-3.80
(-2.00%)
USD |
NASDAQ |
Feb 09, 16:00
186.66
+0.02
(+0.01%)
After-Hours: 20:00
Ligand Pharmaceuticals EPS Diluted (Quarterly) : 5.685 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Johnson & Johnson | 2.098 |
| Elanco Animal Health, Inc. | -0.0684 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Krystal Biotech, Inc. | 2.660 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 117.27M |
| Revenue (Quarterly) | 115.46M |
| Total Expenses (Quarterly) | -1.812M |
| Enterprise Value | 3.460B |
| Gross Profit Margin (Quarterly) | 89.70% |
| Earnings Yield | 1.11% |
| Operating Earnings Yield | 0.79% |
| Normalized Earnings Yield | 0.1209 |